Neo Synth presents the Annual Precision: Breast Cancer World Summit taking place on March 6th and 7th in Boston, USA

Over the two days, this exclusive summit will bring together will bring together senior scientists and business leaders from pharma, biotech and academia, using extensive networking sessions to forge meaningful collaborations.

Breast cancer R&D receives the largest amount of spending across all cancer types, and represents the largest opportunity for developers

The summit will cover the latest updates from the pipelines of small and large drug developers, and feature discussions around the latest trends in precision medicine through case studies from early discovery to development.

Speaker Organizations Include: Merck, Novartis, AstraZeneca, Celldex, Merrimack, etc. 

Topics Include: Antibody Drug Conjugates, Immuno-Oncology, Biomarkers / Companion Diagnostics, etc.